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Introduction:
All countries are classified, for analytical purposes, into three broad classifications, based
off a country’s economic condition.1. The World Economic Situation and Prospects (WESP) is
responsible for these classifications. The gross national income per capita (GNI) is the
measurement used to classify a county’s economy: as developed, in transition or developing. The
United States is an example of a country that is considered developed, while the countries of
Central America are all considered developing.1 This classification system is useful; however, it
may not provide great insight into the health of a nation’s population. Good health of a country’s
population directly effects its economy due to increase in productivity.2 One of the ways a
country can help decrease illnesses is by implementing childhood vaccination programs.
In 1974 the World Health Organization (WHO) realized the importance of vaccinations
and established the Expanded Program on Immunization (EPI); with the goal of making
vaccinations readily available for children worldwide. In 1977, the Pan American Health
Organization (PAHO) established its own EPI for the region.3 This region includes North
America, Central America, Caribbean and South America. The first six targeted vaccine
preventable diseases (VPDs) were diphtheria, whooping cough, tetanus, measles, poliomyelitis
and tuberculosis.3 These VPDs were prioritized based on their overall threat to public health and
the ability to prevent them.4 In 1984 the EPI created the first standardized vaccination schedule
which recommended the following four vaccines against six diseases: tuberculosis (BCG),
diphtheria, tetanus, and pertussis (DPT vaccine), measles (MMR) and poliomyelitis (IPV).5 The
DPT and polio vaccines both have a three-dose series, while the MMR vaccine is a two-dose
series. Overtime changes have been made to vaccination schedules and new vaccinations have
been recommended. In 2011 the Global Vaccine Action Plan (GVAP) was launched by the
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immunization community to help set forward a plan to prevent VPDs through 2020. Overall the
EPI in the Americas has been a major success.6
Since the implantation of the EPI in the Americas in the 1970s the immunization
coverage has increased from 50% to 80%. The Americas have also become the first region,
worldwide, to eliminate poliomyelitis.6 In 2015 and 2016 this region was declared free of
measles, rubella, congenital rubella syndrome and in 2017, neonatal tetatnus.6 The initiative of
PAHO has immensely contributed to the decrease in childhood morbidity and mortality due to
VPDs. With that being said there is still more work that needs to be done in this region.
The PAHO still must tackle many challenges that hinder its ability to vaccinate all
children in this region. These challenges include vaccine hesitancy, access to vaccinations,
inadequate health care practices and cost.6 The Americas still remains one of the most
inequitable regions in the world and there are still millions of people that are unable to access
health services.7 Vaccine hesitancy which is defined by the WHO as a “delay in acceptance or
refusal of vaccines despite availability of vaccination services”, has become such a problem that
the WHO has declared it as a top ten global health threat.8 Countries in this region must also
make sure that their health care providers are up to date on information related to vaccines. This
includes vaccine contraindications and vaccination schedules as well as ensuring their patients
are educated on vaccines. These challenges, if not addressed can lead to lower childhood
vaccination rates which can leave a population more susceptible to VPDs.
Due to the recent short-comings of childhood vaccination rates, prevalence of VPDs in
the Americas are on the rise. Herd immunity is a societal benefit that occurs when a large portion
of the population is immune to a disease which protects people who are not immune. 2 When
immunization coverage for a VPD falls below are certain percentage, herd immunity is more
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likely to fail. This was recently observed when MMR coverage fell in the United States which
allowed for measles to find its way back to the US after being declared eliminated in 2000. 8 It is
important to address barriers that prevent children from receiving vaccines so that solutions can
be implemented accordingly.
The goal of this paper is to analyze how the developing region of Latin America, with a
focus on Central America, fairs in comparison to the United States regarding childhood
immunizations against the six original VPDs. Furthermore, this paper will analyze the recent
drop in immunization coverage in Pan America and some of the barriers these countries face
which hinder their abilities to vaccinate all children. Lastly, probable solutions will be explored
to address some of the challenges these countries face in implementing childhood vaccines.
Background:
Immunization Rates
Every year the WHO/PAHO release a summary of vaccination information of all the
countries they monitor. The most recent summary is the 2018 comprehensive family
immunization brochure which analyzes the immunization coverage of 2017. The WHO has a
recommended vaccine schedule that they put out and update consistently as a guideline that each
country can use as a reference.9 DTP3 immunization coverage is often use as a measurement tool
to gage how well a country is doing in regard to vaccinations, the goal is at least 90% coverage.
Vaccinations against all of the original six VPDs are recommended to be started by the age of
one, MMR vaccine can be started at nine or twelve months. Therefore, all the data on these
vaccinations are of children one-year-old and younger.
In the United States the percent of coverage in 2017 for DTP3, MMR1, and IPV1 was
95%, 92%, and 97% respectively.10 There is no data on the BCG vaccine because it is not
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recommended in the United States. In Central America DTP3 coverage was 90% or above in
Honduras, Nicaragua, and Costa Rica and lower than 90% in Belize, El Salvador, Guatemala and
Panama.10 MMR1 coverage was 85% and 86% in El Salvador and Guatemala respectively, while
the other countries achieved coverage of 90% or higher. El Salvador had an IPV1 coverage of
82% while all of the remaining Central American countries achieved 88% or better percentage.
BCG vaccine coverage was 90% or better in all Central American countries except El Salvador
and Guatemala, 83% and 81% respectively.10
Challenges: Vaccine Hesitancy
Recently, in the region of Pan America an overall drop in DTP3 coverage has been
observed. The PAHO has reported that coverage fell from 91% in 2016 to 88% in 2017,
indicating that almost 1.8 million children under the age of one did not receive their complete
vaccination. One of the factors thought to contribute to this is vaccine hesitancy (VH). VH can
be thought of as a problem that falls on a spectrum, which on one side comprises people who
fully accept the importance of vaccinations to the other side of outright refusers and everyone
else falls in between.11 In the US Immunization rates are good but there has been an increase in
unvaccinated children under the age of two.12 One of the factors that has contributed to VH,
especially in the US, is the spread of false information. A catalyst for vaccine misinformation to
spread happened when a British doctor, Andrew Wakefield, published an article linking the
MMR vaccine to autism, which was later retracted.12 Not only that instance but also prominent
influencers from actor Jim Carey to the President of the United States, Donald Trump, has
expressed misguided concern about the safety of vaccinations. This kind of false information has
contributed to the public’s confusion about vaccine safety.12
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With social media having the outreach it has it makes it easier for falsified information to
spread, unchecked. It was found that VH parents were more likely to be influenced by false
vaccine information found online.8,12 There is not much data about the impact of VH in Central
America. However, with the increase availability of internet in the region there has been informal
reports of growing anti-vaccine attitudes amongst people in parts of Latin America. 13 Overall the
PAHO has found that in Latin America vaccines are viewed as a public good and a political
priority.13
Challenges: Access
Despite increased access to health care in the Americas, there is still huge access
inequalities. These inequalities can be due to many reasons such as wealth distribution,
geographical barriers, and lack of health care services. Between 2014-2015 it was estimated that
1.2 million deaths could have been prevented in the Pan American region if health systems were
more accessible.14 In the Americas 30% of the population still do not have access to health care
because of financial reasons, while 21% do not have access because of geographical barriers. 7 It
is reported that 20% of children, under the age of one, who have DTP coverage lower than 80%,
come from countries in the region that are in the lower income quartile.15
Access to health care services at a subnational level presents as an ongoing challenge in
the US as well as Central America. In the United States and in Panama, it is estimated that access
to physicians in urban areas is 80 percentage points higher than in rural areas.14 The United
States has 86% of their population covered by health insurance but they have the biggest
discrepancy between coverage in regard to the wealthiest and the poorest of households. 14
However, only 1.9% of households in the US reported access barriers as the reason for lacking
health care services.14 While countries like Guatemala attribute differences in vaccine coverage,
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at a municipality level, to longer clinic distances and availability of vaccines. 16 Due to the
discrepancies in health services at the subnational level, many countries in the region have DTP3
coverage rates way lower than what they are reporting nationally.10
Challenges: Health care Providers
Health care providers play a pivotal role in ensuring patients receive vaccinations. Not
only do health care providers administer vaccinations, it is their responsibility to also educate the
populous on the importance of vaccinations. It is imperative that patients trust their providers so
that they comply with what is recommended. However, health care providers sometimes fail to
provide understandable information on vaccines.
With the rise in vaccine hesitancy, especially in the United States, it is important
practitioners build a trusting relationship with their community, making the population more
inclined to follow their medical advice. In the United States trust in institutionalized medicine is
low and the relationship between provider and parent is changing. 12 Parents are now getting used
to a shared-decision-making model with their pediatrician which can lead to problems. 12 One
observational study compared the approach a provider used, regarding vaccinations, as
“presumptive” (i.e., “Johnny has some shots today”) or “participatory” (i.e., “What do you think
about Johnny’s shots today?”). The results showed that when a provider used the participatory
approach, parents were more likely to resist the vaccination reccomendations. 12 There is little
data on parent and provider relationships in Central America, however, studies in Guatemala and
Panama show an overall patient/parent satisfaction and a positive attitude toward
vaccinations.13,16
Health care provider’s practices are not always up to acceptable standards, which can
lead to missed opportunities for vaccination (MOV). MOV can be defined as an instance when a
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child is eligible for vaccination during a visit but does not receive one. One of the reasons for
MOV is because a provider fails to remind the parent that their child is due for a vaccination.
Two studies done in New York and Denver showed that 82.2% and 80%, respectively, of
vaccine eligible visits resulted in MOV.11 In the Denver study they found that 29% of the MOV
was due to providers lack of vaccination recommendation.11 It is estimated that around 89% of
all unvaccinated children could have been vaccinated if they received the proper
recommendations and education on said vaccine.11
In Central America health provider’s practices and protocols present a serious problem,
especially in poor areas, leading to a decrease in immunization coverage. 17 A recent study that
aimed to analyze MOV in Central America, found that there was a reluctance to administer
vaccines due to false contraindications and inadequate knowledge of the vaccination schedule.17
Physicians in this region self-reported knowledge of vaccine contraindications, however, were
still hesitant to administer vaccines when the vaccination was not contraindicated. 17 Furthermore,
this study indicated that providers may not be paying attention to vaccination records which may
lead to MOV.17 In Guatemala, patients reported lack of knowledge regarding immunization
services.16 This shows that failure of health providers to educate patients on vaccines being
administered as well as vaccination schedules can lead to parents becoming confused and
uncertain about their child’s next vaccination.17 In Panama, it was discovered that a high
percentage of MOV were due to false contraindications. 13
Challenges: Cost
The cost of any good must be weighed against the benefits, and that is especially true for
vaccinations. It is globally accepted that administering vaccines improve population health which
leads to economic gains, through illnesses adverted as well as increased productivity.2,6
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Developed countries have an easier time implementing new vaccinations because of their
increased wealth, which allows for more resources to help compare the cost and benefits of
vaccinations. It has been shown that in developing countries, vaccine implementation can
generate a return on investment of 16 times the cost.18 Furthermore, research shows that for every
US dollar invested in childhood vaccination will produce a net return of 44 US dollars. 19
However, implementing new vaccines still remains a challenge for developing countries.
Developing countries that are in the lowest income brackets have additional resources
from outside sources that developing countries in middle income brackets do not qualify for. 1,19
The countries of Central America do not qualify for these external resources so funding for new
vaccines can be hard to acquire.19 Prices of new vaccines are especially high, but tend to lower
over time, so middle income countries usually have a delay in implementing them, regardless of
the long-term return on investment.20 Vaccines do not have a set return on investment that
translates equally between countries because each VPD affects a nation differently based on
overall disease burden.18 This presents as a challenge to developing Central American countries
because they lack data on the disease burden for a lot of VPDs. 21 This makes it hard to compare
the cost of an illness to the cost and benefit of implementing a new vaccine.
Methods:
A literature search was conducted using PubMed, World Health Organization database
and the CDC to gather information on vaccines and immunization coverage in Latin America,
and in the United States. Key words included, “immunization coverage”, “vaccines in the
Americas”, “vaccine preventable diseases”, “vaccine hesitancy”, “country classifications” and
“childhood vaccinations”. Parameters for the inclusion of articles included, full length articles,
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relative data within the last ten years and in English. A total of 22 articles, editorials and journals
were used to conduct this literature review.
Discussion:
Categorizing countries based on their economies may give insight into the wealth of a
country but does wealthier mean better health? The goal of this paper was to examine the health
regarding childhood immunizations in the United States compared to Latin American countries,
with a focus on Central America. Furthermore, with a recent drop in childhood immunization
coverage in the Pan American region, this paper analyzed barriers that these countries face in
vaccinating all of their children.
Despite being the only developed country in the Pan American region, the United States
does not rank at the top in immunization coverage for any of the VPDs that were analyzed.
Updated standards and results regarding the first dose of a polio vaccination found that the
United States ranked fourth out of the eight countries that were investigated. The US ranked fifth
in MMR1 immunization coverage in comparison to the countries of Central America. Lastly, the
United States ranked third for DTP3 coverage. It is important to note that all seven of the Central
American countries still administer BCG vaccine. However, because the US does not have a high
risk of childhood tuberculosis, they no longer have to include the BCG vaccine in their childhood
immunization recommendations. Pertaining to immunization coverage, this literature review
suggests that one cannot assume that developed countries fair better than poorer countries. With
this, the US and Latin America face barriers that impede their abilities to vaccinate all children.
Vaccine hesitancy is now considered one of the biggest threats to global health. This
paper found that this phenomenon affects countries differently. The limited data in Latin
America indicates there is a strong support for childhood vaccinations; on the contrary the US
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struggles in the deterrence of VH. In the United States the phenomenon of “fake news” is
especially prevalent due to the influence of social media. Social media allows for information to
spread faster than ever before, making it impossible to reliably fact check the resources that are
out there. Additionally, prominent public figures within the US have questioned the safety of
vaccines, with some even recommending more holistic approaches.
The United States is now paying the price for vaccine hesitancy with the recent measles
outbreak throughout the nation. According to the CDC, as of July 18, 2019, there has been 1148
reported cases of measles throughout 30 states. While in Central America there has not been one
reported case of measles. However, it is important to note that some countries in Central
America have lower MMR coverage than the US, so one may be confused as to why there is not
any measle breakouts in that region? It is thought that either there has been missed reporting on
possible measle cases or there is just a lower coverage rate needed to achieve heard immunity. 17
Access to vaccinations is another barrier that decreases immunization coverage.
The United states has made headway in ensuring that more people are covered due to the
Affordable Care Act (ACA), allowing more people to be insured. This legislation made it
possible for millions of people to gain access to health services that were not accessible before.
However, health service disparities still exist between the rich and the poor in the United States.
Inequalities in accessing health services is also observed in Central America.
The US and countries of Central America have more health care providers in urban settings
than rural areas. This affects developing countries more because they have less resources,
meaning fewer personal vehicles and less access to public transportation. The consequences of
this was observed in Guatemala which showed in areas where there were longer distances to the
clinic meant lower immunization coverage.16 The analyzed literature and research suggests that
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geographical barriers do not seem to have as big as an impact on immunization coverage in the
US. Both the region of Central America and the United States can improve their health care
provider’s practices, regarding vaccines.
In Central America and in the US, health care providers contribute to the problem of
MOV. In Central America MOV were attributed to providers believing in false contraindications,
even though they reported that they were knowledgeable regarding vaccines. In the United States
one study showed that providers just out right forgot to tell the patient that they were due for a
vaccination.
In the US, parents play an integral role in the decision making regarding the vaccination
of their children. In part, this is due to providers allowing parents to interject by using
“participatory” language instead of being “presumptive”. This type of problem is less prevalent
in Central America due to the overall strong and positive attitudes towards childhood
vaccinations. Both the US and Central America need to ensure that patients are receiving the
vaccine related education that is necessary. By doing so, it will reduce the risks and rates of
miscommunications and, in turn, lower occurrence of MOV.
If done correctly, vaccine implementation has a positive impact on generating a net return
in investment. Both the United States and Central American countries benefit monetarily from
investing in vaccines. These countries see a net return on investment because of decreased costs
from VPD related illnesses as well as gains in economic productivity. The research indicates that
lower and middle-income countries benefit the most from the implementation of childhood
vaccinations. However, challenges still exist in these countries because of the cost of new
vaccines are high. Middle-income countries, like the ones that comprise Central America,
struggle to introduce new vaccines because of funding. Developing countries must make sure
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that they have estimated the overall disease burden before the implementation of the vaccine for
a specific VPD. This will ensure that an overall benefit from introducing a new vaccine will be
observed.
Challenges still lie ahead in ensuring higher childhood immunization coverage for these
countries. However, many solutions are being explored to tackle these barriers. Recently, in the
United States, the president of the American Academy of Pediatrics, Kyle Yasuda, reached out to
Facebook, Google and Pinterest regarding the spread of vaccine misinformation. 8 In doing so
Facebook has already announced that it will be removing pages and posts that promote an antivaccine rhetoric.8 This is very important because it will help stop the spread of false information
in the US, as well in developing countries where more people are gaining access to the internet.
The Global Vaccine Action Plan is another initiative that has been put into place to
ensure childhood vaccinations get the attention it needs and deserves. This initiative is making
sure that each country is held accountable in vaccinating its youth. Every year there is an
assessment released to show how countries are doing on a global scale. 22 This initiative is
important because it allows countries to see targets that they should aim for and guidelines they
can follow that can aid in improving their childhood immunization programs. The GVAP is great
for developing countries so they can see the data and change current programs accordingly.
Data is very important in helping effectively integrating vaccines. Surveillance programs
must be implemented and updated to better track VPDs.4 A country cannot successfully
introduce new vaccines or change vaccination policies without knowing the effects VPDs are
having on its’ population.4 Surveillance programs are also important in tracking breakouts so
populations that are effected can be contained, like seen in the recent measles outbreak in the US.
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Central American countries would benefit from updating surveillance programs to better track
information on VPDs so they can allocate their limited resources accordingly.
Conclusion
Vaccines are a cost-effective method to help promote the health of a nation. It cannot be
presumed that a developed country has higher standards in health services when compared to that
of a developing country. This literature review indicates that in terms of immunization coverage,
the US does not rank superior when compared to the developing countries of Central America.
Both the United States and Latin America face challenges that impedes childhood vaccinations.
These problems include vaccine hesitancy, access to health services, health care provider
complacency and cost. Negative attitudes towards vaccines seem to present the US with its
biggest challenge regarding childhood vaccines. While more resource driven barriers effect
developing countries, in terms of decreased immunization coverage. Fortunately, initiatives are
being implemented and research is being conducted in order to tackle these challenges. It is
imperative to keep prioritizing childhood vaccines so that countries around the world, whether
developed or developing, can reap the benefits of immunizations.
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